Wiley Bros. Aintree Capital, LLC Viatris Inc Transaction History
Wiley Bros. Aintree Capital, LLC
- $5.07 Billion
- Q3 2024
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Viatris Inc stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 46,566 shares of VTRS stock, worth $593,716. This represents 0.01% of its overall portfolio holdings.
Number of Shares
46,566
Previous 22,877
103.55%
Holding current value
$593,716
Previous $243,000
122.22%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding VTRS
# of Institutions
1,103Shares Held
934MCall Options Held
2.71MPut Options Held
2.4M-
Vanguard Group Inc Valley Forge, PA141MShares$1.8 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.18 Billion0.02% of portfolio
-
State Street Corp Boston, MA63.1MShares$805 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$799 Million4.18% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD48.8MShares$622 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $15.5B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...